Cargando…
Polyethylene glycol/polysorbate skin testing can be useful in risk assessment and management of allergic/pseudoallergic reactions to nanolipid/adenoviral vaccines
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Academy of Allergy, Asthma & Immunology
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9902672/ https://www.ncbi.nlm.nih.gov/pubmed/36759085 http://dx.doi.org/10.1016/j.jaip.2022.11.029 |
_version_ | 1784883314662834176 |
---|---|
author | Marchi, Francesco Carabelli, Anna |
author_facet | Marchi, Francesco Carabelli, Anna |
author_sort | Marchi, Francesco |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-9902672 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | American Academy of Allergy, Asthma & Immunology |
record_format | MEDLINE/PubMed |
spelling | pubmed-99026722023-02-07 Polyethylene glycol/polysorbate skin testing can be useful in risk assessment and management of allergic/pseudoallergic reactions to nanolipid/adenoviral vaccines Marchi, Francesco Carabelli, Anna J Allergy Clin Immunol Pract Correspondence and Replies American Academy of Allergy, Asthma & Immunology 2023-02 2023-02-07 /pmc/articles/PMC9902672/ /pubmed/36759085 http://dx.doi.org/10.1016/j.jaip.2022.11.029 Text en © 2022 American Academy of Allergy, Asthma & Immunology. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Correspondence and Replies Marchi, Francesco Carabelli, Anna Polyethylene glycol/polysorbate skin testing can be useful in risk assessment and management of allergic/pseudoallergic reactions to nanolipid/adenoviral vaccines |
title | Polyethylene glycol/polysorbate skin testing can be useful in risk assessment and management of allergic/pseudoallergic reactions to nanolipid/adenoviral vaccines |
title_full | Polyethylene glycol/polysorbate skin testing can be useful in risk assessment and management of allergic/pseudoallergic reactions to nanolipid/adenoviral vaccines |
title_fullStr | Polyethylene glycol/polysorbate skin testing can be useful in risk assessment and management of allergic/pseudoallergic reactions to nanolipid/adenoviral vaccines |
title_full_unstemmed | Polyethylene glycol/polysorbate skin testing can be useful in risk assessment and management of allergic/pseudoallergic reactions to nanolipid/adenoviral vaccines |
title_short | Polyethylene glycol/polysorbate skin testing can be useful in risk assessment and management of allergic/pseudoallergic reactions to nanolipid/adenoviral vaccines |
title_sort | polyethylene glycol/polysorbate skin testing can be useful in risk assessment and management of allergic/pseudoallergic reactions to nanolipid/adenoviral vaccines |
topic | Correspondence and Replies |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9902672/ https://www.ncbi.nlm.nih.gov/pubmed/36759085 http://dx.doi.org/10.1016/j.jaip.2022.11.029 |
work_keys_str_mv | AT marchifrancesco polyethyleneglycolpolysorbateskintestingcanbeusefulinriskassessmentandmanagementofallergicpseudoallergicreactionstonanolipidadenoviralvaccines AT carabellianna polyethyleneglycolpolysorbateskintestingcanbeusefulinriskassessmentandmanagementofallergicpseudoallergicreactionstonanolipidadenoviralvaccines |